Dasatinib 2-year efficacy in patients with chronic-phase chronic myelogenous leukemia (CML-CP) with resistance or intolerance to imatinib (START-C)

• MAURO MJ

収録刊行物

• J Clin Oncol.

  J Clin Oncol. 26 (18), 7009a-, 2008

詳細情報

• CRID: 1574231875589411968
• NII論文ID: 10025160833
• データソース種別:
  • CiNii Articles